We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDSO
76
DELISTED
Medidata Solutions, Inc.
MDSO
| $8.16M | 0.37% |
+90,161
| New | +$7.91M |
|
77
Everest Group
EG
$15.2B
| $8.01M | 0.36% |
+32,409
| New | +$7.78M |
|
78
Darden Restaurants
DRI
$22.5B
| $8M | 0.36% |
65,754
-74,164
| -53% | -$8.83M |
|
79
Intuit
INTU
$81.1B
| $7.81M | 0.35% |
+29,874
| New | +$7.59M |
|
80
ConocoPhillips
COP
$147B
| $7.78M | 0.35% |
127,605
-88,427
| -41% | -$5.5M |
|
81
Allstate
ALL
$66.9B
| $7.62M | 0.34% |
74,938
-110,344
| -60% | -$10.8M |
|
|
VAR
82
DELISTED
Varian Medical Systems, Inc.
VAR
| $7.5M | 0.34% |
55,070
+39,313
| +249% | +$5.25M |
|
83
Electronic Arts
EA
$52.4B
| $7.48M | 0.33% |
+73,829
| New | +$7.03M |
|
84
AutoZone
AZO
$48.3B
| $7.47M | 0.33% |
+6,794
| New | +$7.15M |
|
85
PepsiCo
PEP
$186B
| $7.45M | 0.33% |
+56,801
| New | +$7.28M |
|
86
Omnicom Group
OMC
$22.7B
| $7.42M | 0.33% |
90,572
+56,612
| +167% | +$4.47M |
|
87
Pinnacle West Capital
PNW
$12.9B
| $7.32M | 0.33% |
77,745
-7,055
| -8% | -$672K |
|
|
88
Fidelity National Information Services
FIS
$21.5B
| $7.24M | 0.32% |
59,035
-161,571
| -73% | -$19M |
|
89
United Airlines
UAL
$38.4B
| $7.14M | 0.32% |
81,523
-122,691
| -60% | -$10.4M |
|
|
SIVB
90
DELISTED
SVB Financial Group
SIVB
| $7.11M | 0.32% |
31,661
+18,783
| +146% | +$4.34M |
|
91
Keysight
KEYS
$54.5B
| $7.08M | 0.32% |
78,860
+39,571
| +101% | +$3.36M |
|
92
Lam Research
LRCX
$382B
| $7.07M | 0.32% |
+376,440
| New | +$7.14M |
|
|
CTRA
93
DELISTED
Coterra Energy
CTRA
| $7.05M | 0.32% |
+307,178
| New | +$7.82M |
|
94
ExxonMobil
XOM
$651B
| $7.05M | 0.32% |
+92,006
| New | +$7.12M |
|
95
Parker-Hannifin
PH
$125B
| $7.01M | 0.31% |
41,229
+6,540
| +19% | +$1.13M |
|
96
Unum
UNM
$13.8B
| $6.9M | 0.31% |
205,718
+71,424
| +53% | +$2.47M |
|
|
NLSN
97
DELISTED
Nielsen Holdings plc
NLSN
| $6.88M | 0.31% |
304,524
+143,974
| +90% | +$3.48M |
|
98
Fortinet
FTNT
$112B
| $6.87M | 0.31% |
447,160
+236,370
| +112% | +$3.89M |
|
99
Vornado Realty Trust
VNO
$7.47B
| $6.85M | 0.31% |
106,817
-5,259
| -5% | -$354K |
|
|
DFS
100
DELISTED
Discover Financial Services
DFS
| $6.83M | 0.31% |
+88,081
| New | +$6.82M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.